{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:21:48Z","timestamp":1778538108263,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate the frequency, duration and patterns of long-term coronavirus disease 2019 (COVID-19) symptoms and to analyse risk factors for long-lasting COVID-19 sequelae among a cohort of hospital employees (HEs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a survey regarding persistent COVID-19 related symptoms with all HEs from three medical centres in Cologne, Germany, who were tested SARS-CoV-2 PCR positive from March 2020 until May 2021. Duration of symptoms and possible risk factors for protracted COVID-19 course were analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 221 included HEs, a number of 104 HEs (47.1%) reported at least one persisting symptom for more than 90 days after initial SARS-CoV-2 detection. Each one cycle higher initial Ct value significantly increased the chances of overcoming symptoms (odds ratio [OR] 1.05; 95% confidence interval (95%CI) 1.01\u20131.09; p\u2009=\u20090.019). The occurrence of breathlessness within the first ten days (OR 7.89; 95%CI 1.87\u201341.43; p\u2009=\u20090.008), an initial Ct value under 30 (OR 3.36; 95%CI 1.22\u20139.94; p\u2009=\u20090.022) as well as the occurrence of anosmia or ageusia within the first ten days (OR 3.01; 95%CI 1.10\u20138.84; p\u2009=\u20090.037) showed a statistically significant association with increased odds of illness duration over 90 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>About half of the HEs suffered from long lasting symptoms over 90 days after almost entirely mild acute COVID-19. Predictive factors could possibly be used for early treatment to prevent development of long-term symptoms after COVID-19 in future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08710-1","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T08:02:19Z","timestamp":1705996939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long-term symptoms after SARS-CoV-2 infection in a cohort of hospital employees: duration and predictive factors"],"prefix":"10.1186","volume":"24","author":[{"given":"Rosalie","family":"Gruber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Ver\u00f3nica","family":"Montilva Ludewig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"We\u00dfels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerlinde","family":"Schlang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svenja","family":"Jedhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swetlana","family":"Herbrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frauke","family":"Mattner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"issue":"3","key":"8710_CR1","doi-asserted-by":"publisher","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","volume":"55","author":"CC Lai","year":"2020","unstructured":"Lai CC, Shih TP, Ko WC, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105924. Epub 2020 Feb 17. PMID: 32081636; PMCID: PMC7127800.","journal-title":"Int J Antimicrob Agents"},{"issue":"13","key":"8710_CR2","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382(13):1199\u2013207. https:\/\/doi.org\/10.1056\/NEJMoa2001316. Epub 2020 Jan 29. PMID: 31995857; PMCID: PMC7121484.","journal-title":"N Engl J Med"},{"issue":"1","key":"8710_CR3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1186\/s12913-023-09601-6","volume":"23","author":"A Gandjour","year":"2023","unstructured":"Gandjour A, Long COVID. Costs for the German economy and health care and pension system. BMC Health Serv Res. 2023;23(1):641. https:\/\/doi.org\/10.1186\/s12913-023-09601-6. PMID: 37316880; PMCID: PMC10266873.","journal-title":"BMC Health Serv Res"},{"key":"8710_CR4","unstructured":"Robert Koch-Institut RKI. COVID-19 Dashboard. 2021. https:\/\/experience.arcgis.com\/experience\/478220a4c454480e823b17327b2bf1d4 (accessed 17.02.2022)."},{"issue":"8","key":"8710_CR5","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","volume":"20","author":"WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection","year":"2020","unstructured":"WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20(8):e192\u2013e7.","journal-title":"Lancet Infect Dis"},{"issue":"10270","key":"8710_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","volume":"397","author":"C Huang","year":"2021","unstructured":"Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220\u201332.","journal-title":"Lancet"},{"issue":"5","key":"8710_CR7","doi-asserted-by":"publisher","first-page":"e2111417","DOI":"10.1001\/jamanetworkopen.2021.11417","volume":"4","author":"T Nasserie","year":"2021","unstructured":"Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and Variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw open. 2021;4(5):e2111417.","journal-title":"JAMA Netw open"},{"issue":"10","key":"8710_CR8","doi-asserted-by":"publisher","first-page":"e2128568","DOI":"10.1001\/jamanetworkopen.2021.28568","volume":"4","author":"D Groff","year":"2021","unstructured":"Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of Postacute Sequelae of SARS-CoV-2 Infection: a systematic review. JAMA Netw open. 2021;4(10):e2128568.","journal-title":"JAMA Netw open"},{"key":"8710_CR9","doi-asserted-by":"crossref","unstructured":"Vedel S\u00f8rensen AI, Spiliopoulos L, Bager P, et al. Post-acute symptoms, new onset diagnoses and health problems 6 to 12 months after SARS-CoV-2 Infection: a nationwide questionnaire study in the adult Danish population. medRxiv. 2022. 2022.02.27.22271328.","DOI":"10.1101\/2022.02.27.22271328"},{"key":"8710_CR10","doi-asserted-by":"publisher","first-page":"100122","DOI":"10.1016\/j.lanepe.2021.100122","volume":"6","author":"M Augustin","year":"2021","unstructured":"Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Europe. 2021;6:100122.","journal-title":"Lancet Reg Health Europe"},{"key":"8710_CR11","unstructured":"National Institute for Health and Care Excellence (NICE)., Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP) (2022), COVID-19 rapid guideline: managing the longterm effects of COVID-19. Version 1.14 published on 01.03.2022 (accessed 10.08.2023)."},{"key":"8710_CR12","unstructured":"World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. 2021. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1."},{"issue":"3","key":"8710_CR13","doi-asserted-by":"publisher","first-page":"100088","DOI":"10.1016\/j.jcvp.2022.100088","volume":"2","author":"J Wanney","year":"2022","unstructured":"Wanney J, L\u00fcsebrink J, Sp\u00f6lgen G, et al. Direct comparison of Altona-SARS-CoV-2 dual target RT-qPCR assay with commercial LAMP assay using throat washes in health care staff testing. J Clin Virol Plus. 2022;2(3):100088. https:\/\/doi.org\/10.1016\/j.jcvp.2022.100088. Epub 2022 Jun 2. PMID: 35669098; PMCID: PMC9159961.","journal-title":"J Clin Virol Plus"},{"key":"8710_CR14","doi-asserted-by":"publisher","first-page":"114202","DOI":"10.1016\/j.jviromet.2021.114202","volume":"295","author":"M Malecki","year":"2021","unstructured":"Malecki M, Luesebrink J, Wendel AF, et al. Analysis of external quality assessment samples revealed crucial performance differences between commercial RT-PCR assays for SARS-CoV-2 detection when taking extraction methods and real-time-PCR instruments into account. J Virol Methods. 2021;295:114202. https:\/\/doi.org\/10.1016\/j.jviromet.2021.114202. Epub 2021 Jun 2. PMID: 34087340; PMCID: PMC8169234.","journal-title":"J Virol Methods"},{"key":"8710_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/POR.S316186","volume":"12","author":"R Jones","year":"2021","unstructured":"Jones R, Davis A, Stanley B, et al. Risk predictors and Symptom features of Long COVID within a Broad Primary Care Patient Population including both tested and untested patients. Pragmatic and Observational Research. 2021;12:93\u2013104.","journal-title":"Pragmatic and Observational Research"},{"issue":"1","key":"8710_CR16","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1186\/s12889-021-11013-2","volume":"21","author":"E Westerlind","year":"2021","unstructured":"Westerlind E, Palstam A, Sunnerhagen KS, Persson HC. Patterns and predictors of sick leave after Covid-19 and long Covid in a national Swedish cohort. BMC Public Health. 2021;21(1):1023.","journal-title":"BMC Public Health"},{"key":"8710_CR17","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. 2021. https:\/\/www.R-project.org\/."},{"key":"8710_CR18","first-page":"1","volume":"4","author":"S Epskamp","year":"2012","unstructured":"Epskamp S, Cramer AOJ, Waldorp LJ, Schmittmann VD, Borsboom D. Qgraph: network visualizations of relationships in Psychometric Data. J Stat Soft. 2012;4:1\u201318.","journal-title":"J Stat Soft"},{"key":"8710_CR19","unstructured":"Therneau TM. A Package for Survival Analysis in R. 2021. https:\/\/CRAN.R-project.org\/package=survival."},{"key":"8710_CR20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life tables. J R Stat Soc. 1972;34:187\u2013202.","journal-title":"J R Stat Soc"},{"key":"8710_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/0471249688","volume-title":"Categorical Data Analysis","author":"A Agresti","year":"2002","unstructured":"Agresti A. Categorical Data Analysis. 2nd ed. New York: John Wiley & Sons; 2002.","edition":"2"},{"key":"8710_CR22","unstructured":"Robert Koch-Institut. COVID-19: Entlassungskriterien aus der Isolierung. 2023. https:\/\/edoc.rki.de\/bitstream\/handle\/176904\/6867\/20_0316_Entlasskriterien_A3_V11.pdf?sequence=1&isAllowed=y: (accessed 10.08.2023)."},{"key":"8710_CR23","unstructured":"Robert Koch-Institut. Hinweise zur Testung von Patientinnen und Patienten auf SARS-CoV-2. 2023. https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Vorl_Testung_nCoV.html (accessed 10.08.2023)."},{"issue":"2","key":"8710_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cmi.2020.09.052","volume":"27","author":"C Carvalho-Schneider","year":"2020","unstructured":"Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2020;27(2):258\u201363.","journal-title":"Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis"},{"key":"8710_CR25","doi-asserted-by":"crossref","unstructured":"Roessler M, Tesch F, Batram M et al. Post COVID-19 in children, adolescents, and adults: results of a matched cohort study including more than 150,000 individuals with COVID-19. medRxiv 2021: 2021.10.21.21265133.","DOI":"10.1101\/2021.10.21.21265133"},{"issue":"2","key":"8710_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","volume":"23","author":"S Mehandru","year":"2022","unstructured":"Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194\u2013202.","journal-title":"Nat Immunol"},{"key":"8710_CR27","doi-asserted-by":"crossref","unstructured":"Zazhytska M, Kodra A, Hoagland DA et al. Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell 2022.","DOI":"10.1101\/2021.02.09.430314"},{"key":"8710_CR28","doi-asserted-by":"crossref","unstructured":"Etter MM, Martins A, Kulsvehagen T. L, Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and signs of neurodegeneration: a prospective cross-sectional study. medRxiv 2022: 2022.02.18.22271039.","DOI":"10.1101\/2022.02.18.22271039"},{"issue":"3","key":"8710_CR29","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.dsx.2021.04.007","volume":"15","author":"AV Raveendran","year":"2021","unstructured":"Raveendran AV, Jayadevan R, Sashidharan S, Long COVID. An overview. Diabetes & Metabolic Syndrome. 2021;15(3):869\u201375.","journal-title":"Diabetes & Metabolic Syndrome"},{"issue":"10","key":"8710_CR30","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/23744235.2021.1924397","volume":"53","author":"SJ Yong","year":"2021","unstructured":"Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53(10):737\u201354.","journal-title":"Infect Dis"},{"key":"8710_CR31","doi-asserted-by":"crossref","unstructured":"Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med 2022.","DOI":"10.1038\/s41591-022-01689-3"},{"key":"8710_CR32","doi-asserted-by":"crossref","unstructured":"Karimzadeh S, Bhopal R, Nguyen Tien H. Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses. Epidemiol Infect. 2021;149:e96. doi: 10.1017\/S0950268821000790. Erratum in: Epidemiol Infect. 2021;149:e116. PMID: 33849679; PMCID: PMC8082124.","DOI":"10.1017\/S0950268821000790"},{"key":"8710_CR33","doi-asserted-by":"crossref","unstructured":"Van Damme W, Dahake R, van de Pas R et al. COVID-19: does the infectious inoculum dose-response relationship contribute to understanding heterogeneity in Disease severity and transmission dynamics? Medical hypotheses, Volume 146, 2021,110431.","DOI":"10.1016\/j.mehy.2020.110431"},{"key":"8710_CR34","doi-asserted-by":"publisher","first-page":"e068414","DOI":"10.1136\/bmj-2021-068414","volume":"376","author":"K Cohen","year":"2022","unstructured":"Cohen K, Ren S, Heath K, et al. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 Infection: retrospective cohort study. BMJ. 2022;376:e068414.","journal-title":"BMJ"},{"issue":"8","key":"8710_CR35","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","volume":"28","author":"A Subramanian","year":"2022","unstructured":"Subramanian A, Nirantharakumar K, Hughes S, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706\u201314.","journal-title":"Nat Med"},{"issue":"6","key":"8710_CR36","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/jamainternmed.2023.0743","volume":"183","author":"Y Xie","year":"2023","unstructured":"Xie Y, Choi T, Al-Aly Z. Association of Treatment with Nirmatrelvir and the risk of Post-COVID-19 Condition. JAMA Intern Med. 2023;183(6):554\u201364.","journal-title":"JAMA Intern Med"},{"key":"8710_CR37","doi-asserted-by":"crossref","unstructured":"Kuodi P, Gorelik Y, Zayyad H et al. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021. medRxiv 2022: 2022.01.05.22268800.","DOI":"10.1101\/2022.01.05.22268800"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08710-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08710-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08710-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T17:47:52Z","timestamp":1731088072000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08710-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8710"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08710-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.03.22.22272770","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-2812977\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,23]]},"assertion":[{"value":"13 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Ethical approval was obtained from the ethics committee of Witten\/Herdecke University (S-273\/2021). Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}